Literature DB >> 7428673

The sustained antihypertensive effect of chronic cerebroventricular infusion of angiotensin antagonist in spontaneously hypertensive rats.

W McDonald, C Wickre, S Aumann, D Ban, B Moffitt.   

Abstract

The angiotensin antagonist [Sar1-Ile8]angiotensin II was infused into the lateral ventricles of mature spontaneously hypertensive and normotensive Wistar-Kyoto rats. Infusions were maintained at rats of 1200 ng/h for 6 days, and blood pressure was measured daily in the unanesthetized state. Blood pressure reduction occurred promptly and only in the hypertensive animals. This antihypertensive effect persisted for several days after discontinuation of the infusion. In contrast, iv infusion of the angiotensin antagonist at comparable doses failed to alter blood pressure in any significant fashion. These data suggest that the brain isorenin system participates in the maintenance of hypertension in the spontaneously hypertensive rat.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7428673     DOI: 10.1210/endo-107-5-1305

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

Review 1.  The role of neuropeptides in cardiovascular regulation.

Authors:  D Ganten; M Paul; R E Lang
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

2.  Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.

Authors:  M W Bunting; R E Widdop
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

3.  Prevention by blockade of angiotensin subtype1-receptors of the development of genetic hypertension but not its heritability.

Authors:  P Madeddu; V Anania; M V Varoni; P P Parpaglia; M P Demontis; M C Fattaccio; D Palomba; D Pollock; N Glorioso
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

Review 4.  Angiotensin-converting enzyme 2 in the brain: properties and future directions.

Authors:  Huijing Xia; Eric Lazartigues
Journal:  J Neurochem       Date:  2008-11-05       Impact factor: 5.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.